Thank you to our speakers, sponsors, and delegates who joined us in Boston!
NEXT IN THE SERIES:
3rd mRNA-Based Therapeutics Summit Europe
Berlin, Germany | 23rd-25th January, 2024
Welcome to the largest gathering for mRNA professionals
With over 800 mRNA drugs now in development and the industry accelerating towards clinical success, the mRNA-Based Therapeutics Summit returned for its 3rd year as the industry’s largest networking opportunity to date, showcasing exclusive new data from the movers and shakers in the field.
Attendees ensured their whole team were able to stay ahead of the curve by joining 425+ key mRNA opinion leaders from Moderna, BioNTech, CureVac, Pfizer and Sanofi including regulatory insights from the FDA and EMA at the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
In 2023, 425+ attendees heard insights from 100+ world-class speakers from large pharma, innovative biotechs, and academia, across 3 days of jam-packed content and 5 dedicated tracks (discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics) deep-dive focus and workshop days, C-Level Fireside Discussions and more. Attendees overcame industry hurdles including optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!
2023 World-Class Speaker Faculty Included:
Peter Marks
Director - Center for Biologics Evaluation & Research
US Food & Drug Administration (FDA)
Frank DeRosa
Chief Technology Officer & Global Head of Research, Biomarkers & Messenger Ribonucleic Acid, Center of Excellence
Sanofi
Who Attended in 2023?
The Biggest Meeting in the 2023 mRNA Calendar
425+
Attendees
100+
World-Class Speakers
10+
Hours of Dedicated In-Person Networking
5
Tracks of Content
2
Pre-Conference Days
1
Pre-Conference Workshop Day
5
Interactive Panel Discussions
2023 Lead Partner
2023 Hosting Partners
2023 Expertise Partners
